TUSTIN, Calif., March 6, 2013 /PRNewswire/ -- MicroVention, Inc.,
a wholly owned subsidiary of Terumo Corporation, announced that its
new manufacturing facility in San Jose,
Costa Rica is now open. The Company also held a Grand
Opening Ceremony today to commemorate this exciting new venture for
MicroVention. The new plant represents MicroVention's first
manufacturing facility outside the United
States and the first Neurovascular manufacturing facility in
Costa Rica, which is located at
the Coyol Free Zone in the Alajuela region of Costa Rica.
The Plant Opening Ceremony was attended by numerous dignitaries
and executives from the business district including the Vice
President of Costa Rica,
Luis Lieberman Ginsburg. Other
executives who attended from MicroVention's parent company included
Mr. Yutaro Shintaku, President and
Representative Director; Mr. Shinjiro
Sato, Senior Executive Officer, Group President, Cardiac and
Vascular Business Group, both of Terumo Corporation located in
Tokyo, Japan and Mr. Hideo Arase, President and CEO of Terumo
Americas Holding. Also in attendance was the Costa Rican
Investment Promotion Agency (CINDE) which has supported
MicroVention in establishing its plant in Costa Rica. "MicroVention will
be the first company specializing in the neurovascular segment, and
we are excited to welcome MicroVention to the Alajuela region,"
commented Gabriela Llobet, CINDE´s
Director General.
This new facility will support the growth and expansion of
products offered under the MicroVention and Terumo brand and the
Company has hired approximately 150 Associates with plans to expand
in the coming months/years. The new plant is located just
outside of San Jose, the nation's
capital (the size of the new facility is 7,500 M2/80,000
sq. ft. and will encompass a 2,300 M2 clean room/25,000
sq. ft.).
"We are very excited about the initiation of our first
manufacturing facility in Costa
Rica and commemorating the opening with many of our
new partners celebrating with us. Our intent was to create a
world-class facility extension of our corporate manufacturing plant
in Tustin, CA, USA, and we have
achieved that goal today," said Richard
Cappetta, President and Chief Executive Officer of
MicroVention, Inc. In attendance besides the Company's
President and CEO were several other members of the MicroVention
Executive Staff including William R.
Hughes, Chief Operating Officer and Treasurer; Cherie Henket, Vice President, Human Resources;
Matt Fitz, Sr. Vice President,
Research and Development and Operations; Mr. Uichi Okina, Vice President, Strategic Planning,
Business Development; and Charlie
Noel, Vice President, Operations.
Approximately 12,000 people currently work in the Life Sciences
Sector in Costa Rica with 41
medical device companies producing orthopedic, cardiovascular,
women's health devices, and medical supplies. MicroVention will be
the first company specializing in the neurovascular segment
in Costa Rica. MicroVention has been recruiting its first
employees, specifically in the areas of Engineering, Quality,
Production and Administration. Persons interested in applying can
visit the "Careers – Costa Rica"
page of the MicroVention website at www.microvention.com.
About Terumo Corporation
Tokyo-based Terumo Corporation
is one of the world's leading medical device manufacturers with
$5 billion in sales and operations in
more than 160 nations. Founded in 1921, the company develops,
manufactures and distributes world-class medical devices including
products for use in cardiothoracic surgery, interventional
procedures and transfusion medicine; the company also manufactures
a broad array of syringe and hypodermic needle products for
hospital and physician office use. Terumo contributes to
society by providing valued products and services to the health
care market and by responding to the needs of health care providers
and the people they serve. Terumo Corporation's shares are
listed on the first section of the Tokyo Stock Exchange (No. 4543,
Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a
component of the Nikkei 225, Japan's leading stock index.
About MicroVention, Inc.
MicroVention, Inc. is a U.S. subsidiary of Terumo Corporation
with its corporate headquarters in Tustin, California, and manufacturing and
administrative facilities in Santa
Ana and Aliso Viejo,
California, and San Jose,
Costa Rica. MicroVention is a developer, manufacturer and
marketer of innovative neuroendovascular technologies for the
treatment of vascular diseases in small vessels. MicroVention
products are sold throughout the world in more than 60
countries. For more information, visit
www.microvention.com.
Media Contact:
Cathy Demyanovich
Sr. Director, Corporate Communications
MicroVention. Inc.
800-990-8361
714-247-8000
SOURCE MicroVention, Inc.
